Experimental and bioinformatic characterisation of the promoter region of the Marfan syndrome gene, FBN1

Genomics

Volumn 94, Issue 4, 2009, Pages 233-240

  Summers, Kim M ^a,b   Bokil, Nilesh J ^b   Baisden, John M ^b   West, Malcolm J ^b   Sweet, Matthew J ^b   Raggatt, Liza J ^b   Hume, David A ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Dominant genetic conditions; Fibrillin 1; Gene expression; Marfan syndrome; Mesenchyme; Promoter regions; Reporter genes

Indexed keywords

FIBRILLIN 1; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL DIFFERENTIATION; CONTROLLED STUDY; CPG ISLAND; EMBRYO; EXTRACELLULAR MATRIX; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL; MARFAN SYNDROME; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; TRANSCRIPTION INITIATION SITE;

ANIMALS; BASE PAIRING; BASE SEQUENCE; BINDING SITES; CELL LINE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; CPG ISLANDS; EXONS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, DOMINANT; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUCIFERASES; MARFAN SYNDROME; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SEQUENCE ANALYSIS, PROTEIN; TRANSCRIPTION INITIATION SITE;

MAMMALIA;

EID: 70249147186     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.06.005     Document Type: Article

References (48)

1. Dietz H.C., et al. Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J. Clin. Invest. 89 (1992) 1674-1680
2. Summers K.M., et al. An integrated approach to management of Marfan syndrome caused by an FBN1 exon 18 mutation in an Australian Aboriginal family. Clin. Genet. 65 (2004) 66-69
3. Pyeritz R.E. The Marfan syndrome. Annu. Rev. Med. 51 (2000) 481-510
4. Summers K.M., West J.A., Peterson M.M., Stark D., McGill J.J., and West M.J. Challenges in the diagnosis of Marfan syndrome. Med. J. Aust. 184 (2006) 627-631
5. Hutchinson S., et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype. Hum. Mol. Genet. 12 (2003) 2269-2276
6. Judge D.P., et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J. Clin. Invest. 114 (2004) 172-181
7. Matyas G., et al. Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome. Hum. Genet. 122 (2007) 23-32
8. Singh K.K., Shukla P.C., Rommel K., Schmidtke J., and Arslan-Kirchner M. Sequence variations in the 5′ upstream regions of the FBN1 gene associated with Marfan syndrome. Eur. J. Hum. Genet. 14 (2006) 876-879
9. de Koning D.J., and Haley C.S. Genetical genomics in humans and model organisms. Trends Genet. 21 (2005) 377-381
10. Hubner N., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37 (2005) 243-253
11. Corson G.M., Chalberg S.C., Dietz H.C., Charbonneau N.L., and Sakai L.Y. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 17 (1993) 476-484
12. Guo G., Bauer S., Hecht J., Schulz M.H., Busche A., and Robinson P.N. A short ultraconserved sequence drives transcription from an alternate FBN1 promoter. Int. J. Biochem. Cell Biol. 40 (2008) 638-650
13. Singh K.K., Shukla P.C., and Schmidtke J. Conservation of 5′-upstream region of the FBN1 gene in primates. Eur. J. Hum. Genet. 16 (2008) 869-872
14. Kitahama S., et al. Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone 27 (2000) 61-67
15. Carninci P., et al. The transcriptional landscape of the mammalian genome. Science 309 (2005) 1559-1563
16. Frith M.C., Valen E., Krogh A., Hayashizaki Y., Carninci P., and Sandelin A. A code for transcription initiation in mammalian genomes. Genome Res. 18 (2008) 1-12
17. Gardiner-Garden M., and Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196 (1987) 261-282
18. Bieda M., Xu X., Singer M.A., Green R., and Farnham P.J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16 (2006) 595-605
19. Vernell R., Helin K., and Muller H. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278 (2003) 46124-46137
20. Blyth K., Cameron E.R., and Neil J.C. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 5 (2005) 376-387
21. Levitsky V.G. RECON: a program for prediction of nucleosome formation potential. Nucleic Acids Res. 32 (2004) W346-W349
22. Nataatmadja M., et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108 Suppl 1 (2003) II329-II334
23. Schaefer G.B., and Godfrey M. Quantitation of fibrillin immunofluorescence in fibroblast cultures in the Marfan syndrome. Clin. Genet. 47 (1995) 144-149
24. Summers K.M., et al. Histopathology and fibrillin-1 distribution in severe early onset Marfan syndrome. Am. J. Med. Genet. A 139 (2005) 2-8
25. Carninci P., et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat. Genet. 38 (2006) 626-635
26. Sasmono R.T., et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101 (2003) 1155-1163
27. Sandelin A., Carninci P., Lenhard B., Ponjavic J., Hayashizaki Y., and Hume D.A. Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat. Rev. Genet. 8 (2007) 424-436
28. Rochette-Egly C., Fromental C., and Chambon P. General repression of enhanson activity by the adenovirus-2 E1A proteins. Genes Dev. 4 (1990) 137-150
29. Berk A.J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24 (2005) 7673-7685
30. Bajic V.B., et al. Mice and men: their promoter properties. PLoS Genet. 2 (2006) e54
31. Larkin M.A., et al. Clustal W and Clustal X version 2.0. Bioinformatics 23 (2007) 2947-2948
32. Matys V., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34 (2006) D108-D110
33. Vlieghe D., et al. A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res. 34 (2006) D95-D97
34. Chappell K.J., Stoermer M.J., Fairlie D.P., and Young P.R. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J. Biol. Chem. 281 (2006) 38448-38458
35. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17 (2007) 318-324
36. Shin C.S., et al. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J. Mol. Endocrinol. 36 (2006) 531-546
37. Greco S.J., Liu K., and Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25 (2007) 3143-3154
38. Nishimoto M., Miyagi S., Katayanagi T., Tomioka M., Muramatsu M., and Okuda A. The embryonic Octamer factor 3/4 displays distinct DNA binding specificity from those of other Octamer factors. Biochem. Biophys. Res. Commun. 302 (2003) 581-586
39. Buckingham M., and Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 23 (2007) 645-673
40. Naya F.J., and Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11 (1999) 683-688
41. ten Berge D., Brouwer A., Korving J., Martin J.F., and Meijlink F. Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbs. Development 125 (1998) 3831-3842
42. Jay P.Y., et al. Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects. Dev. Biol. 301 (2007) 602-614
43. Mauritz C., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118 (2008) 507-517
44. Polager S., and Ginsberg D. E2F - at the crossroads of life and death. Trends Cell Biol. 18 (2008) 528-535
45. Scheijen B., Bronk M., van der Meer T., and Bernards R. Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation. Mol. Cell. Biol. 23 (2003) 3656-3668
46. Cohen Jr. M.M. The new bone biology: pathologic, molecular, and clinical correlates. Am. J. Med. Genet. A 140 (2006) 2646-2706
47. Seki K., et al. Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. J. Biol. Chem. 278 (2003) 41862-41870
48. Arnold H.H., and Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8 (1998) 539-544